These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2022062)

  • 1. Thyroxine replacement in post-radioiodine hypothyroidism.
    Bearcroft CP; Toms GC; Williams SJ; Noonan K; Monson JP
    Clin Endocrinol (Oxf); 1991 Feb; 34(2):115-8. PubMed ID: 2022062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
    Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
    Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioactive iodine therapy for pediatric Graves' disease: a single-center experience over a 10-year period.
    Kaplowitz PB; Jiang J; Vaidyanathan P
    J Pediatr Endocrinol Metab; 2020 Mar; 33(3):383-389. PubMed ID: 31603857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intentional radioiodine ablation in Graves' disease.
    Wise PH; Burnet RB; Ahmad A; Harding PE
    Lancet; 1975 Dec; 2(7947):1231-3. PubMed ID: 53722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
    Franklyn JA; Daykin J; Holder R; Sheppard MC
    QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The early development of transient and permanent hypothyroidism following radioiodine therapy for hyperthyroid Graves' disease.
    Peden NR; Hart IR
    Can Med Assoc J; 1984 May; 130(9):1141-4. PubMed ID: 6546895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A reappraisal of the role of methimazole and other factors on the efficacy and outcome of radioiodine therapy of Graves' hyperthyroidism.
    Marcocci C; Gianchecchi D; Masini I; Golia F; Ceccarelli C; Bracci E; Fenzi GF; Pinchera A
    J Endocrinol Invest; 1990 Jun; 13(6):513-20. PubMed ID: 2258580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does early administration of thyroxine reduce the development of Graves' ophthalmopathy after radioiodine treatment?
    Tallstedt L; Lundell G; Blomgren H; Bring J
    Eur J Endocrinol; 1994 May; 130(5):494-7. PubMed ID: 8180678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of Global DNA Methylation and DNA Methyltransferase Expression in T and B Lymphocytes from Patients with Newly Diagnosed Autoimmune Thyroid Diseases After Treatment: A Follow-Up Study.
    Guo Q; Wu D; Yu H; Bao J; Peng S; Shan Z; Guan H; Teng W
    Thyroid; 2018 Mar; 28(3):377-385. PubMed ID: 29336230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone mineral density in thyroxine treated females with or without a previous history of thyrotoxicosis.
    Franklyn J; Betteridge J; Holder R; Daykin J; Lilley J; Sheppard M
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):425-32. PubMed ID: 7955453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results of radioiodine (131I) therapy in 331 patients with Graves' disease.
    Saito S; Sakurada T; Yamamoto M; Yoshida K; Kaise K; Kaise N; Yoshinaga K
    Tohoku J Exp Med; 1980 Sep; 132(1):1-10. PubMed ID: 6894205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioiodine therapy in Graves' disease patients with large diffuse goiters treated with or without carbimazole at the time of radioiodine therapy.
    Sabri O; Zimny M; Schreckenberger M; Reinartz P; Ostwald E; Buell U
    Thyroid; 1999 Dec; 9(12):1181-8. PubMed ID: 10646656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The action of methimazole and L-thyroxine in radioiodine therapy: a prospective study on the incidence of hypothyroidism.
    Kung AW; Yau CC; Cheng AC
    Thyroid; 1995 Feb; 5(1):7-12. PubMed ID: 7787438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of treatment failure, incipient hypothyroidism, and weight gain following radioiodine therapy for Graves' thyrotoxicosis.
    Gibb FW; Zammitt NN; Beckett GJ; Strachan MW
    J Endocrinol Invest; 2013 Oct; 36(9):764-9. PubMed ID: 23633646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioactive iodine ablation therapy: a viable option in the management of Graves' disease in Nigeria.
    Adedapo KS; Fadiji IO; Orunmuyi AT; Onimode Y; Osifo BO
    Afr J Med Med Sci; 2012 Dec; 41 Suppl():193-6. PubMed ID: 23678656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factor analysis in 325 patients with Graves' disease treated with radioiodine therapy.
    Yang D; Xue J; Ma W; Liu F; Fan Y; Rong J; Yang A; Yu Y
    Nucl Med Commun; 2018 Jan; 39(1):16-21. PubMed ID: 29040161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient Hypothyroidism after Radioiodine for Graves' Disease: Challenges in Interpreting Thyroid Function Tests.
    Sheehan MT; Doi SA
    Clin Med Res; 2016 Mar; 14(1):40-5. PubMed ID: 26864507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compensated low-dose 131I therapy of Graves' disease.
    Roudebush CP; Hoye KE; DeGroot LJ
    Ann Intern Med; 1977 Oct; 87(4):441-3. PubMed ID: 578665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal daily levothyroxine dose in primary hypothyroidism. Its relation to pretreatment thyroid hormone indexes.
    Kabadi UM
    Arch Intern Med; 1989 Oct; 149(10):2209-12. PubMed ID: 2508585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioiodine treatment of hyperthyroidism-prognostic factors for outcome.
    Allahabadia A; Daykin J; Sheppard MC; Gough SC; Franklyn JA
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3611-7. PubMed ID: 11502786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.